The Taxpayers Protection Alliance (TPA) submitted testimony to the Georgia General Assembly’s Joint Tax Credit Review Panel against tax incentives and taxpayer subsidies in Georgia. Georgia legislators should look to…
Last week, the Taxpayers Protection Alliance (TPA) submitted information to the House Budget Committee’s Health Care Task Force regarding ways the U.S. can improve patient outcomes and reduce federal health…
Last week, the Taxpayers Protection Alliance (TPA) submitted information to the House Budget Committee’s Health Care Task Force regarding ways the U.S. can improve patient outcomes and reduce federal health…
This was originally published in the American Institute for Economic Research on October 9th, 2023. The Federal Trade Commission (FTC) late last month filed suit against Amazon as an alleged monopolist (in two…
In light of Federal Communications Commission (FCC) Chairwoman Jessica Rosenworcel’s plan to attempt to reclassify the internet as a Title II telecommunications service under the Communications Act of 1934, fellow…
On Thursday, October 5th, the Wisconsin State Legislature’s committee on state affairs held a public hearing for Assembly Bill’s 438 and 439, in relation to funding for the Milwaukee Brewers…
World Mental Health Day is observed on October 10th. This year’s theme is “Mental Health is a Universal Human Right.” Many people may not know that smoking rates are disproportionally…
For more than a decade, the UK National Health Service (NHS) has used October to promote a public health campaign urging the 6.4 million smoking adults to quit during the…
While this lawsuit is indicative of an unhealthy tech antitrust obsession on the part of American regulators, it also reveals a fundamental misunderstanding of markets in a technological age. Administrative staff have predicated a number of antitrust actions based on market definitions that are outdated at best and deceptively manipulated at worst. In an increasingly interconnected world, lawmakers and enforcers have to reconsider what constitutes a market in a given area.
The Biden administration announced that the manufacturers of the first ten drugs selected for the Inflation Reduction Act’s (IRA) price negotiation program under Medicare agreed to participate in the process. In a September 11, 2023 op-ed, TPA noted, “Basic economics says that when a product’s production costs rise and its sales revenues fall, firms will produce less of it. By excising manufacturers’ incentive to produce, price controls invariably lead to stunted innovation, worse product quality, and supply shortages. The pharmaceutical industry has no special immunity from this basic economic phenomenon.
